Background Vaccines can be less immunogenic in people living with HIV (PLWH), but for
SARS-CoV-2 vaccinations this is unknown. In this study we set out to investigate, for the …

Purpose To describe the humoral immune response to COVID-19 vaccines in people living
with HIV and identify factors associated with the magnitude of anti-SARS-CoV-2 antibody …

Objectives The aim of this study was to assess the immunogenicity of SARS-CoV-2 available
vaccines among people living with HIV (PLWH) after a complete vaccination scheme, and …

This study aims to assess the immunological response and impact on virological control of
the mRNA vaccines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Objective: To evaluate the safety and the serological response after two doses of mRNA-
based SARS-CoV-2 vaccination in people with HIV (PWH). Methods: Participants were …

Background Inactivated COVID-19 vaccines are safe and effective in the general population
with intact immunity. However, their safety and immunogenicity have not been demonstrated …

Objectives Available data show that COVID-19 vaccines may be less effective in people
living with HIV (PLWH) who are at increased risk for severe COVID-19. This meta-analysis …

Objectives We estimated the effectiveness of COVID-19 vaccines against laboratory-
confirmed SARS-CoV-2 infection among people living with HIV (PLWH) and compared the …

Background: Data on SARS-CoV-2 vaccine immunogenicity in PLWH are currently limited.
Aim of the study was to investigate immunogenicity according to current CD4 T-cell count …

Backgrounds To date, the effects of SARS-CoV-2 vaccines on people living with HIV (PLWH)
were mainly focused on messenger RNA (mRNA) and adenovirus vector-based vaccines …